Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Broadcom
AVGO
|
+$67.3M |
| 2 |
Veralto
VLTO
|
+$60.2M |
| 3 |
Newmont
NEM
|
+$43.4M |
| 4 |
Vertiv
VRT
|
+$19.4M |
| 5 |
Webster Financial
WBS
|
+$17.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$328M |
| 2 |
Microsoft
MSFT
|
+$244M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$237M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$109M |
Sector Composition
| 1 | Technology | 30.91% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.36% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Viridian Therapeutics
VRDN
$1.6B
| $1.46M | ﹤0.01% |
67,200
+800
| +1% | +$17.4K |
|
|
PDS
2027
Precision Drilling
PDS
$756M
| $1.46M | ﹤0.01% |
26,900
-3,100
| -10% | -$169K |
|
2028
Nabors Industries
NBR
$619M
| $1.46M | ﹤0.01% |
17,900
-2,000
| -10% | -$163K |
|
2029
Pediatrix Medical
MD
$1.48B
| $1.46M | ﹤0.01% |
157,100
-17,800
| -10% | -$166K |
|
2030
Global Industrial
GIC
$1.47B
| $1.46M | ﹤0.01% |
37,500
-3,900
| -9% | -$151K |
|
2031
ODDITY Tech
ODD
$3.52B
| $1.46M | ﹤0.01% |
+31,300
| New | +$1.46M |
|
2032
Merchants Bancorp
MBIN
$1.47B
| $1.45M | ﹤0.01% |
34,100
-3,900
| -10% | -$166K |
|
2033
Tompkins Financial
TMP
$1.02B
| $1.45M | ﹤0.01% |
24,100
-2,900
| -11% | -$175K |
|
2034
Maravai LifeSciences
MRVI
$404M
| $1.45M | ﹤0.01% |
221,000
-25,500
| -10% | -$167K |
|
|
RVNC
2035
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.45M | ﹤0.01% |
164,650
-20,100
| -11% | -$177K |
|
2036
Medifast
MED
$153M
| $1.45M | ﹤0.01% |
21,500
-2,400
| -10% | -$161K |
|
2037
Interface
TILE
$1.67B
| $1.44M | ﹤0.01% |
114,500
-13,000
| -10% | -$164K |
|
2038
Dine Brands
DIN
$372M
| $1.44M | ﹤0.01% |
29,100
-3,400
| -10% | -$169K |
|
2039
Ethan Allen Interiors
ETD
$753M
| $1.44M | ﹤0.01% |
45,100
-5,100
| -10% | -$163K |
|
|
HAYN
2040
DELISTED
Haynes International, Inc.
HAYN
| $1.43M | ﹤0.01% |
25,100
-2,900
| -10% | -$165K |
|
2041
Centrus Energy
LEU
$4.08B
| $1.43M | ﹤0.01% |
26,300
-1,300
| -5% | -$70.7K |
|
2042
FuelCell Energy
FCEL
$209M
| $1.43M | ﹤0.01% |
29,800
| – | – |
|
2043
Aehr Test Systems
AEHR
$795M
| $1.43M | ﹤0.01% |
53,900
-5,300
| -9% | -$141K |
|
|
INN
2044
Summit Hotel Properties
INN
$626M
| $1.42M | ﹤0.01% |
212,000
-24,300
| -10% | -$163K |
|
2045
Byline Bancorp
BY
$1.33B
| $1.42M | ﹤0.01% |
60,300
+6,900
| +13% | +$163K |
|
|
ORLA
2046
Orla Mining
ORLA
$3.73B
| $1.42M | ﹤0.01% |
434,900
-50,900
| -10% | -$166K |
|
2047
ProAssurance
PRA
$1.22B
| $1.41M | ﹤0.01% |
102,600
-16,100
| -14% | -$222K |
|
2048
Enviri
NVRI
$987M
| $1.41M | ﹤0.01% |
157,200
-18,100
| -10% | -$163K |
|
|
PKST
2049
Peakstone Realty Trust
PKST
$506M
| $1.41M | ﹤0.01% |
70,900
-8,200
| -10% | -$163K |
|
2050
ChargePoint
CHPT
$235M
| $1.41M | ﹤0.01% |
30,160
-2,845
| -9% | -$133K |
|